ZURA
Zura Bio Limited Class A Ordinary Shares
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
ZURA Stock Analysis: Buy, Sell, or Hold?
$1.41
+0.17 (+13.31%)
▲
5d:
-64.79%
30d:
-64.88%
90d:
-75.69%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$3.07 – $4.53
Position: OVERSOLD
Forward P/E & Valuation
-2.1x
Next 12M consensus est.
Wall Street Target
$19.00
+1252.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.93 / $4.60
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ZURA is down 64.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ZURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ZURA is currently trading at $1.41, which is considered oversold relative to its 30-day fair value range of $3.07 to $4.53.
Technical Outlook: Technically, ZURA is in a downtrend. Immediate support is located at $0.93, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 13.3% recently.
Market Sentiment: ZURA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.00 (+1252.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZURA is in a downtrend. Immediate support is located at $0.93, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 13.3% recently.
Market Sentiment: ZURA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.00 (+1252.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.07 -
$4.53
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
Trading Range & Key Levels
30-Day Trading Range
$3.07 -
$4.53
Current vs Trading Range
OVERSOLD
Support Level
$0.93
Resistance Level
$4.60
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.3%)
- BULLISH: Trading 1252.3% below Wall St target ($19.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.07
Wall Street Target
$19.00
(+1252.3%)
Share ZURA Analysis
Share this live ZURA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ZURA)
Bullish
4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Despite disappointing news of Zura Bio discontinuing the development of tibulizumab for hidradenitis suppurativa following a Phase II trial failure, stockTwits messages exhibit unanimous bullish sentiment.
Key Retail Themes:
recovery potential
future growth prospects
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:44 AM ET
Data refreshes hourly during market hours. Next update: 10:44 AM
Data refreshes hourly during market hours. Next update: 10:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZURA Research Pages
